StonvexLoading…
StonvexStonvexStonvexCore line items from CSGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.25B | $2.74B | $2.46B | $2.18B |
Operating Income | $-72.00M | $5.00M | $282.00M | $451.00M |
Net Income | $7.00M | $139.00M | $375.00M | $369.50M |
EPS (Diluted) | $0.02 | $0.34 | $0.92 | $0.93 |
Total Assets | $10.54B | $9.26B | $8.92B | $8.40B |
Total Liabilities | $2.17B | $1.70B | $1.58B | $1.53B |
Cash & Equivalents | $1.63B | $4.68B | $5.20B | $5.00B |
Free Cash Flow OCF − CapEx | $123.00M | $-186.00M | $372.00M | $443.50M |
Shares Outstanding | 417.90M | 409.50M | 408.10M | 406.70M |